epsilon-Amanitin
Internal ID | 2aca0a52-4133-46c7-86f2-fd6464748b41 |
Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Cyclic peptides > Amatoxins |
IUPAC Name | 2-[34-butan-2-yl-8,22-dihydroxy-13-(3-hydroxybutan-2-yl)-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetic acid |
SMILES (Canonical) | CCC(C)C1C(=O)NCC(=O)NC2CS(=O)C3=C(CC(C(=O)NCC(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)CC(=O)O)O)C(C)C(C)O)C5=C(N3)C=C(C=C5)O |
SMILES (Isomeric) | CCC(C)C1C(=O)NCC(=O)NC2CS(=O)C3=C(CC(C(=O)NCC(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)CC(=O)O)O)C(C)C(C)O)C5=C(N3)C=C(C=C5)O |
InChI | InChI=1S/C39H53N9O14S/c1-5-16(2)31-36(59)41-12-28(52)42-26-15-63(62)38-22(21-7-6-19(50)8-23(21)45-38)10-24(33(56)40-13-29(53)46-31)43-37(60)32(17(3)18(4)49)47-35(58)27-9-20(51)14-48(27)39(61)25(11-30(54)55)44-34(26)57/h6-8,16-18,20,24-27,31-32,45,49-51H,5,9-15H2,1-4H3,(H,40,56)(H,41,59)(H,42,52)(H,43,60)(H,44,57)(H,46,53)(H,47,58)(H,54,55) |
InChI Key | OFILNAORONITPV-UHFFFAOYSA-N |
Popularity | 0 references in papers |
Molecular Formula | C39H53N9O14S |
Molecular Weight | 904.00 g/mol |
Exact Mass | 903.34326857 g/mol |
Topological Polar Surface Area (TPSA) | 374.00 Ų |
XlogP | -2.70 |
Atomic LogP (AlogP) | -4.29 |
H-Bond Acceptor | 13 |
H-Bond Donor | 12 |
Rotatable Bonds | 6 |
21705-02-2 |
2-[34-butan-2-yl-8,22-dihydroxy-13-(3-hydroxybutan-2-yl)-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetic acid |
DTXSID201028142 |
alpha-Amanitin, 1-L-aspartic acid-3-((S)-4-hydroxy-L-isoleucine)- |
alpha-Amanitin, 1-L-aspartic acid-3-(4-hydroxy-L-isoleucine)-, (S)- |
AKOS040757381 |
9,18-(Iminoethaniminoethaniminoethaniminomethano)pyrrolo(1',2':8,9)(1,5,8,11,14)thiatetraazacyclooctadecino(18,17-b)indole-6-acetic acid, 1,2,3,5,6,7,8,9,10,12,17,18,19,20,21,22,23,23a-octadecahydro-29-sec-butyl-2,14-dihydroxy-21-(2-hydroxy-1-methylpropyl)-5,8,20,23,24,27,30,33-octaoxo-, 11-oxide |
Cyclo(L-alpha-aspartyl-4-hydroxy-L-prolyl-(S)-4-hydroxy-L-isoleucyl-6-hydroxy-2-mercapto-L-tryptophylglycyl-L-isoleucylglycyl-L-cysteinyl), cyclic (4-8)-sulfide, (R)-8-oxide |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.8167 | 81.67% |
Caco-2 | - | 0.8711 | 87.11% |
Blood Brain Barrier | - | 0.8250 | 82.50% |
Human oral bioavailability | - | 0.7000 | 70.00% |
Subcellular localzation | Lysosomes | 0.4326 | 43.26% |
OATP2B1 inhibitior | - | 0.5912 | 59.12% |
OATP1B1 inhibitior | + | 0.7838 | 78.38% |
OATP1B3 inhibitior | + | 0.9330 | 93.30% |
MATE1 inhibitior | - | 0.9000 | 90.00% |
OCT2 inhibitior | - | 0.7500 | 75.00% |
BSEP inhibitior | + | 0.9129 | 91.29% |
P-glycoprotein inhibitior | + | 0.7353 | 73.53% |
P-glycoprotein substrate | + | 0.8777 | 87.77% |
CYP3A4 substrate | + | 0.7125 | 71.25% |
CYP2C9 substrate | - | 0.8035 | 80.35% |
CYP2D6 substrate | - | 0.8484 | 84.84% |
CYP3A4 inhibition | - | 0.7854 | 78.54% |
CYP2C9 inhibition | - | 0.7157 | 71.57% |
CYP2C19 inhibition | - | 0.7074 | 70.74% |
CYP2D6 inhibition | - | 0.8647 | 86.47% |
CYP1A2 inhibition | - | 0.7103 | 71.03% |
CYP2C8 inhibition | + | 0.7836 | 78.36% |
CYP inhibitory promiscuity | - | 0.7557 | 75.57% |
UGT catelyzed | + | 0.7000 | 70.00% |
Carcinogenicity (binary) | - | 0.5700 | 57.00% |
Carcinogenicity (trinary) | Non-required | 0.6039 | 60.39% |
Eye corrosion | - | 0.9824 | 98.24% |
Eye irritation | - | 0.9078 | 90.78% |
Skin irritation | - | 0.7633 | 76.33% |
Skin corrosion | - | 0.9196 | 91.96% |
Ames mutagenesis | - | 0.7054 | 70.54% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.4366 | 43.66% |
Micronuclear | + | 0.8700 | 87.00% |
Hepatotoxicity | - | 0.6447 | 64.47% |
skin sensitisation | - | 0.8410 | 84.10% |
Respiratory toxicity | + | 0.8000 | 80.00% |
Reproductive toxicity | + | 0.8667 | 86.67% |
Mitochondrial toxicity | + | 0.8750 | 87.50% |
Nephrotoxicity | - | 0.8009 | 80.09% |
Acute Oral Toxicity (c) | III | 0.5420 | 54.20% |
Estrogen receptor binding | + | 0.8136 | 81.36% |
Androgen receptor binding | + | 0.7440 | 74.40% |
Thyroid receptor binding | + | 0.5797 | 57.97% |
Glucocorticoid receptor binding | + | 0.5581 | 55.81% |
Aromatase binding | + | 0.5966 | 59.66% |
PPAR gamma | + | 0.7550 | 75.50% |
Honey bee toxicity | - | 0.7111 | 71.11% |
Biodegradation | - | 0.9000 | 90.00% |
Crustacea aquatic toxicity | - | 0.5000 | 50.00% |
Fish aquatic toxicity | + | 0.9595 | 95.95% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL2581 | P07339 | Cathepsin D | 99.79% | 98.95% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.37% | 96.09% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 99.03% | 94.45% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.29% | 91.11% |
CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 95.00% | 91.71% |
CHEMBL255 | P29275 | Adenosine A2b receptor | 92.92% | 98.59% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 92.59% | 89.00% |
CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 92.11% | 82.38% |
CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 91.92% | 90.08% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 91.86% | 95.56% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 90.60% | 97.09% |
CHEMBL2535 | P11166 | Glucose transporter | 90.58% | 98.75% |
CHEMBL1902 | P62942 | FK506-binding protein 1A | 89.86% | 97.05% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 89.14% | 99.17% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 88.87% | 85.14% |
CHEMBL1781 | P11387 | DNA topoisomerase I | 88.61% | 97.00% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 87.79% | 95.93% |
CHEMBL206 | P03372 | Estrogen receptor alpha | 86.91% | 97.64% |
CHEMBL217 | P14416 | Dopamine D2 receptor | 86.32% | 95.62% |
CHEMBL4071 | P08311 | Cathepsin G | 86.20% | 94.64% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 86.10% | 90.71% |
CHEMBL2443 | P49862 | Kallikrein 7 | 85.72% | 94.00% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 85.54% | 99.23% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 85.46% | 93.56% |
CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 84.76% | 95.56% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 84.72% | 95.89% |
CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 84.44% | 88.56% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 84.10% | 96.90% |
CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 84.05% | 89.62% |
CHEMBL5697 | Q9GZT9 | Egl nine homolog 1 | 84.02% | 93.40% |
CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 83.98% | 94.62% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 83.63% | 93.00% |
CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 83.37% | 95.00% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 83.32% | 86.33% |
CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 83.05% | 90.93% |
CHEMBL1907 | P15144 | Aminopeptidase N | 82.69% | 93.31% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 81.50% | 97.14% |
CHEMBL1821 | P08173 | Muscarinic acetylcholine receptor M4 | 80.76% | 94.08% |
CHEMBL256 | P0DMS8 | Adenosine A3 receptor | 80.52% | 95.93% |
CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 80.15% | 97.23% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 80.00% | 95.89% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Acanthochlamys bracteata |
PubChem | 30508 |
LOTUS | LTS0126611 |
wikiData | Q2760181 |